Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Maze Therapeutics, Inc.
SIC 2836 · Biological Products (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Maze Therapeutics, Inc.
SIC 2836 · Biological Products (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Maze Therapeutics, Inc.
SIC 2836 · Biological Products (No Diagnostic Substances)
Notes
Support
about
terms
$
MAZE
Maze Therapeutics, Inc.
CIK:
0001842295
|
SEC Filings
ARTICLES AND BYLAWS
EX-3.1
d769642dex31.htm
2025-01-27T00:00:00Z
EX-3.1
d769642dex31.htm
2025-01-07T00:00:00Z
EX-3.3
d769642dex33.htm
2025-01-07T00:00:00Z
EX-3.4
d769642dex34.htm
2025-01-07T00:00:00Z
EX-3.2
d769642dex32.htm
2025-01-07T00:00:00Z
EX-3.1
maze-ex3_1.htm
2025-03-31T00:00:00Z
EX-3.2
maze-ex3_2.htm
2025-03-31T00:00:00Z
EX-3.1
filename2.htm
2024-12-06T00:00:00Z
EX-3.1
filename2.htm
2024-06-21T00:00:00Z
EX-3.3
filename3.htm
2024-06-21T00:00:00Z